Alexandra is responsible for identifying and characterizing novel CRISPR-based gene editing tools at Life Edit Therapeutics.
She has more than seven years of experience as an early investigator in the CRISPR genome editing field. With her bioinformatics and microbiology background, she has produced two published patents, more than a dozen patent applications, and 18 peer-reviewed publications.
Alexandra graduated from North Carolina State University with a PhD in Functional Genomics.
.svg)
.svg)
To rewrite the future by curing disease, making any edit, anywhere.
To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.
We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.
